Navigation Links
DURECT to Participate in Cowen and Company Healthcare Conference
Date:3/9/2009

CUPERTINO, Calif., March 9 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Matthew Hogan, Chief Financial Officer, will be presenting at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009 at 8:00 a.m. EDT. The conference is being held at the Marriott Hotel in Boston.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing DURECT's homepage at www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY(TM), POSIDUR(TM), ELADUR(TM), and TRANSDUR(TM)-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit www.durect.com.

NOTE: POSIDUR(TM), SABER(TM), ORADUR(R), TRANSDUR(TM), and ELADUR(TM) are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners. REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the US Food and Drug Administration or other health authorities.


'/>"/>
SOURCE DURECT Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
2. DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call
3. DURECT Corporation to Participate in Upcoming Healthcare Conferences
4. DURECT Corporation to Participate in Upcoming Healthcare Conferences
5. DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
6. DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology
7. DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call
8. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
9. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
10. DURECT to Participate in Morgan Stanley Global Healthcare Conference
11. DURECT Provides Update on CHRONOGESIC(R) Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... The preeminent surgical aftercare ... Dickinson needed following breast cancer surgery. In March 2016, the 61-year-old model and reality ... breast cancer that occurs in the milk ducts, according to an interview with ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... in medical coding, billing and compliance. In upcoming months, AudioEducator has lined up ... specialties. Every conference is designed to give complete compliance know-how and practical, easy-to-apply ...
(Date:5/4/2016)... Columbia – , ... ... , a manufacturer of innovative infant and child products, today revealed ... But their ability to help babies deal with teething pain is ... approved, contain no toxic gels, and are BPA-, PVC-, and phthalate-free. ...
(Date:5/4/2016)... ... 2016 , ... DESCO Medical Service, also known as Diagnostic ... service and sales company located in Pennsylvania. The terms of the deal were ... management services to the medical and academic research industries. The acquisition will help ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... Scientific Group is scheduled on July 25-27, 2016 at Las Vegas. It aims ... care professionals from educational institutes and research organizations across the globe; making the ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... India , April 29, 2016 ... Pipeline Review, H1 2016" market research report that ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:4/29/2016)... , April 29, 2016 /PRNewswire/ ... Contamine, Directeur Financier Sanofi, ... santé, publie ses résultats pour le ... du Groupe, Jérôme Contamine, commente les ... et les perspectives pour le reste ...
(Date:4/29/2016)... India , April 29, 2016 ... the life science laboratory due to the growing demands ... by advance technology, contemporary automated systems are already adept ... performed by slow, tedious and manual labor. Instrumentation continues ... were not even conceivable just a few years ago. ...
Breaking Medicine Technology: